UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

The New England journal of medicine, 2017-06, Vol.376 (22), p.2122-2133

2017

Volltextzugriff (PDF)

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

World journal of gastroenterology : WJG, 2018-10, Vol.24 (37), p.4217-4223

2018

Volltextzugriff (PDF)

Epigenetic changes in patients with multiple sclerosis

Nature reviews. Neurology, 2013-01, Vol.9 (1), p.35-43

2013

Volltextzugriff (PDF)

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

Continuum (Minneapolis, Minn.), 2019-06, Vol.25 (3), p.670-688

Metz, Luanne M

2019

Volltextzugriff (PDF)

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Canadian journal of neurological sciences, 2022-05, Vol.49 (3), p.393-397

2022

Volltextzugriff (PDF)

Effective treatment of progressive MS remains elusive

The Lancet (British edition), 2018-03, Vol.391 (10127), p.1239-1240

2018

Volltextzugriff (PDF)

Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial

Neurology, 2021-05, Vol.96 (18)

2021

Volltextzugriff (PDF)

Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic

Nature communications, 2017-12, Vol.8 (1), p.1990-15, Article 1990

2017

Volltextzugriff (PDF)

Cannabinoids and bladder symptoms in multiple sclerosis

Multiple sclerosis and related disorders, 2021-09, Vol.54, p.103105-103105, Article 103105

2021

Volltextzugriff (PDF)

The promise of minocycline in neurology

Lancet neurology, 2004-12, Vol.3 (12), p.744-751

2004

Volltextzugriff (PDF)

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis

Trends in molecular medicine, 2013-01, Vol.19 (1), p.23-30

2013

Volltextzugriff (PDF)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

BMC neurology, 2021-10, Vol.21 (1), p.1-418, Article 418

2021

Volltextzugriff (PDF)

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241273045

2024

Volltextzugriff (PDF)

Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2017-05, Vol.114 (19), p.4999-5004

2017

Volltextzugriff (PDF)

Ischemic Strokes in a Man with Congenital Afibrinogenemia

Canadian journal of neurological sciences, 2018-09, Vol.45 (5), p.590-592

2018

Volltextzugriff (PDF)

Quality of life, respiratory symptoms, and health care utilization 1 year following outpatient management of COVID-19: a prospective cohort study

Scientific reports, 2022-07, Vol.12 (1), p.12988-12988, Article 12988

2022

Volltextzugriff (PDF)

The natural history of early versus late disability accumulation in primary progressive MS

Journal of neurology, neurosurgery and psychiatry, 2015-06, Vol.86 (6), p.615-621

2015

Volltextzugriff (PDF)

Discriminative ability of quality of life measures in multiple sclerosis

Health and quality of life outcomes, 2017-12, Vol.15 (1), p.246-246, Article 246

2017

Volltextzugriff (PDF)

Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes

Multiple sclerosis and related disorders, 2016-01, Vol.5, p.53-65

2016

Volltextzugriff (PDF)

Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarate

Multiple sclerosis and related disorders, 2023-06, Vol.74, p.104699-104699, Article 104699

2023

Volltextzugriff (PDF)

Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment

Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105525-105525, Article 105525

2024

Volltextzugriff (PDF)

Treatment trials in progressive MS--current challenges and future directions

Nature reviews. Neurology, 2013-09, Vol.9 (9), p.496-503

2013

Volltextzugriff (PDF)

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers

Frontiers in neurology, 2022-05, Vol.13, p.904757-904757

2022

Volltextzugriff (PDF)

Long noncoding RNAs associated with phenotypic severity in multiple sclerosis

Multiple sclerosis and related disorders, 2019-11, Vol.36, p.101407-101407, Article 101407

2019

Volltextzugriff (PDF)

Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis

Journal of neuroimaging, 2021-09, Vol.31 (5), p.981-994

2021

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

Epigenetic changes in patients with multiple sclerosis

Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis

Multiple Sclerosis Clinic Utilization is Associated with Fewer Emergency Department Visits

Effective treatment of progressive MS remains elusive

Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial

Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic

Cannabinoids and bladder symptoms in multiple sclerosis

The promise of minocycline in neurology

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics

Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis

Ischemic Strokes in a Man with Congenital Afibrinogenemia

Quality of life, respiratory symptoms, and health care utilization 1 year following outpatient management of COVID-19: a prospective cohort study

The natural history of early versus late disability accumulation in primary progressive MS

Discriminative ability of quality of life measures in multiple sclerosis

Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes

Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarate

Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment

Treatment trials in progressive MS--current challenges and future directions

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers

Long noncoding RNAs associated with phenotypic severity in multiple sclerosis

Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis

Aktive Filter

Suchergebnisse filtern